Organic Letters
Letter
(3) McElroy, W. D. Proc. Natl. Acad. Sci. U. S. A. 1947, 33, 342.
(4) (a) Taori, K.; Paul, V. J.; Luesch, H. J. Am. Chem. Soc. 2008, 130,
1806. (b) Gerwick, W. H.; Proteau, P. J.; Nagle, D. G.; Hamel, E.;
Blokhin, A.; Slate, D. J. Org. Chem. 1994, 59, 1243. (c) White, J. D.;
Kim, T.-S.; Nambu, M. J. Am. Chem. Soc. 1995, 117, 5612. (d)
Reference 2a. (e) Fukuyama, T.; Xu, L. J. Am. Chem. Soc. 1993, 115,
8449. (f) Wipf, P.; Xu, W. J. Org. Chem. 1996, 61, 6556.
(5) (a) Pellissier, H. Tetrahedron 2007, 63, 1297. (b) Mellah, M.;
Voituriez, A.; Schulz, E. Chem. Rev. 2007, 107, 5133.
(6) (a) Maltsev, O. V.; Walter, V.; Brandl, M. J.; Hintermann, L.
Synthesis 2013, 45, 2763. (b) Charette, A. B.; Chua, P. J. Org. Chem.
1998, 63, 908. (c) North, M.; Pattenden, G. Tetrahedron 1990, 46,
8267. (d) Busacca, C. A.; Dong, Y.; Spinelli, E. M. Tetrahedron Lett.
1996, 37, 2935. (e) Diness, F.; Nielsen, D. S.; Fairlie, D. P. J. Org.
Chem. 2011, 76, 9845. (f) Fukuhara, T.; Hasegawa, C.; Hara, S.
Synthesis 2007, 2007, 1528. (g) Wipf, P.; Miller, C. P.; Venkatraman,
S.; Fritch, P. C. Tetrahedron Lett. 1995, 36, 6395. (h) Reference 1b.
(7) (a) Nishio, T. Tetrahedron Lett. 1995, 36, 6113. (b) Seijas, J. A.;
Figure 2. Derivatizations of thiazoline.
renders the synthesis of a wide array of thiazoline structures
possible while containing functional groups capable of further
synthetic elaborations. In addition, examples of derivatizing the
thiazoline core to the corresponding β-aminothiol or thiazole
via hydrolysis or oxidation, respectively, have been demon-
strated. Most importantly, the limitation in β-aminothiol
availability from condensation methods can be addressed by
the utilization of simple and readily available alkene and
thioamide substrates using this one-pot procedure.
Vaz
́
quez-Tato, M. P.; Crecente-Campo, J. Tetrahedron 2008, 64, 9280.
(c) Mercey, G.; Breg
Tetrahedron Lett. 2008, 49, 6553.
́
eon, D.; Gaumont, A.-C.; Levillain, J.; Gulea, M.
(8) (a) Wipf, P.; Fritch, P. C. Tetrahedron Lett. 1994, 35, 5397.
(b) Lemercier, B. C.; Pierce, J. G. Org. Lett. 2014, 16, 2074.
(c) Tanaka, K.; Nomura, K.; Oda, H.; Yoshida, S.; Mitsuhashi, K. J.
Heterocycl. Chem. 1991, 28, 907.
ASSOCIATED CONTENT
* Supporting Information
(9) Carey, F. A.; Sundberg, R. J. Advanced Organic Chemistry,5th ed.;
■
S
Springer: New York, 2007; Vol. 1, pp 473−569.
(10) (a) Yde, B.; Yousif, N. M.; Pedersen, U.; Thomsen, I.;
Lawesson, S. O. Tetrahedron 1984, 40, 2047. (b) Zali-Boeini, H.;
Mansouri, S. G. Synth. Commun. 2015, 45, 1681.
The Supporting Information is available free of charge on the
(11) Gratia, S. S.; Vigneau, E. S.; Eltayeb, S.; Patel, K.; Meyerhoefer,
T. J.; Kershaw, S.; Huang, V.; Castro, M. D. Tetrahedron Lett. 2014, 55,
448.
Experimental procedure and characterization data of the
(12) (a) Silveira, P. B.; Monteiro, A. L. J. Mol. Catal. A: Chem. 2006,
247, 1. (b) Piou, T.; Rovis, T. J. Am. Chem. Soc. 2014, 136, 11292.
(c) Yar, M.; McGarrigle, E. M.; Aggarwal, V. K. Angew. Chem., Int. Ed.
2008, 47, 3784.
(13) (a) Barhate, N. B.; Gajare, A. S.; Wakharkar, R. D.; Bedekar, A.
V. Tetrahedron 1999, 55, 11127. (b) Kumar, M. A.; Naresh, M.;
Rohitha, C. N.; Narender, N. Synth. Commun. 2013, 43, 3121.
(c) Yang, L.; Lu, Z.; Stahl, S. S. Chem. Commun. 2009, 6460.
(d) Biswanath, D.; Yallamalla, S.; Chittaluri, S.; Kongara, D.; Ravirala,
N. Synth. Commun. 2009, 39, 220. (e) Ying, T.; Bao, W.; Zhang, Y. J.
Chem. Res. 2004, 2004, 806.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Notes
The authors declare no competing financial interest.
(14) 1,2-Disubstituted cis-stilbene (15%) and trans-β-methylstyrene
(<10%) work with low efficiency and stereospecificity.
ACKNOWLEDGMENTS
We gratefully acknowledge the University of Toledo for
financial support with a start-up fund.
■
́
(15) Mercey, G.; Bregeon, D.; Gaumont, A.-C.; Levillain, J.; Gulea,
M. Tetrahedron Lett. 2008, 49, 6553.
(16) Li, X.; Li, C.; Yin, B.; Li, C.; Liu, P.; Li, J.; Shi, Z. Chem. - Asian J.
2013, 8, 1408.
REFERENCES
■
(1) (a) Davyt, D.; Serra, G. Mar. Drugs 2010, 8, 2755. (b) Gaumont,
A.-C.; Gulea, M.; Levillain, J. Chem. Rev. 2009, 109, 1371.
(c) Majumdar, K. C.; Chattopadhyay, S. K. In Heterocycles in Natural
Product Synthesis; Xu, Z., Ye, T., Eds.; Wiley-VCH, 2011.
(2) For anticancer activities, see: (a) Carmeli, S.; Moore, R. E.;
Patterson, G. M. L. J. Am. Chem. Soc. 1990, 112, 8195. (b) Carmeli, S.;
Moore, R. E.; Patterson, G. M. L. Tetrahedron Lett. 1991, 32, 2593.
For anti-HIV activities, see: (c) Jansen, R.; Kunze, B.; Reichenbach,
H.; Jurkiewicz, E.; Hunsmann, G.; Hofle, G. Liebigs Ann. Chem. 1992,
̈
1992, 357. (d) Croxtall, J. D.; Perry, C. M. Drugs 2010, 70, 1885. For
antibiotic activities, see: (e) Yamaguchi, H.; Nakayama, Y.; Takeda, K.;
Tawara, K.; Maeda, K.; Takeuchi, T.; Umezawa, H. J. Antibiot. 1957,
195. (f) Guay, D. R. P. Clin. Ther. 2002, 24, 473. For neurological
activity, see: (g) Lin, Z.; Antemano, R. R.; Hughen, R. W.; Tianero, M.
D. B.; Peraud, O.; Haygood, M. G.; Concepcion, G. P.; Olivera, B. M.;
Light, A.; Schmidt, E. W. J. Nat. Prod. 2010, 73, 1922. (h) Kvernmo,
T.; Hartter, S.; Burger, E. Clin. Ther. 2006, 28, 1065. For a review on
̈
̈
2,4-disubstituted thiazoles as bioactive molecules, see: (i) Arora, P.;
Narang, R.; Nayak, S. K.; Singh, S. K. Med. Chem. Res. 2016, 25, 1717.
D
Org. Lett. XXXX, XXX, XXX−XXX